Literature DB >> 3038217

Use of laser-UV for inactivation of virus in blood products.

K N Prodouz, J C Fratantoni, E J Boone, R F Bonner.   

Abstract

Inactivation of virus by UV radiation was examined as a potential method for sterilization of blood products. Samples of attenuated poliovirus, platelets and plasma were uniformly irradiated with a XeCl excimer laser that delivered 40 nsec pulses of UV at 308 nm (UVB308). Intensities and exposure does were varied from 0.11 to 1.40 MW/cm2 and 0.51 to 56.0 J/cm2, respectively. In studies conducted with low intensity UVB308 (less than or equal to 0.17 MW/cm2), using exposure doses greater than or equal to 10.8 J/cm2, it was possible to inactivate poliovirus by 4 to 6 log10. Platelets irradiated with doses less than or equal to 21.5 J/cm2 exhibited minimal damage as assessed by aggregation activity and spontaneous release of serotonin. Examination of the coagulation activity of irradiated plasma indicated that exposure doses less than or equal to 21.5 J/cm2 resulted in less than 20% increase in prothrombin and partial thromboplastin times. The use of UVB308 at a higher intensity (1.4 MW/cm2) over a similar range of exposure doses did not enhance viral inactivation but did result in increased damage to platelet and plasma proteins. These results demonstrate that at 308 nm there exists a "window of efficacy" for exposure doses between 10.8 and 21.5 J/cm2 and peak intensities less than or equal to 0.17 MW/cm2 in which a hardy virus is significantly inactivated and platelets and plasma proteins are, by functional criteria, minimally affected. Increased viral inactivation cannot be accomplished with higher UV intensities and will require additional or alternate measures.

Entities:  

Mesh:

Year:  1987        PMID: 3038217

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  2 in total

1.  [Evolution of techniques for preparation of labile blood products (LBP): pathogen inactivation in LBP].

Authors:  C Naegelen; H Isola; D Dernis; J-P Maurel; R Tardivel; S Bois; C Vignoli; J-P Cazenave
Journal:  Transfus Clin Biol       Date:  2009-05-13       Impact factor: 1.406

2.  Ultrafast-UV laser integrating cavity device for inactivation of SARS-CoV-2 and other viruses.

Authors:  Sharad Ambardar; Mark C Howell; Karthick Mayilsamy; Andrew McGill; Ryan Green; Subhra Mohapatra; Dmitri V Voronine; Shyam S Mohapatra
Journal:  Sci Rep       Date:  2022-07-13       Impact factor: 4.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.